Gene Bridges and BASF sign collaboration agreement
Heidelberg-based recombineering company Gene Bridges has signed a collaboration agreement with BASF to use Gene Bridges' Red/ET recombination technology alongside BASF's expertise in biotechnology, process development and product application.
Heidelberg-based recombineering company Gene Bridges has signed a collaboration agreement with BASF to use Gene Bridges' Red/ET recombination technology alongside BASF's expertise in biotechnology, process development and product application.
Red/ET is a revolutionary method for DNA engineering. Recombineering with Red/ET allows unlimited cloning, subcloning, and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including very large ones such as BACs or the E.coli chromosome.
Under the terms of the agreement, Gene Bridges will provide bio-molecular engineering for strain optimisation, while BASF will be responsible for subsequent screening and product and process development. The new agreement is a significant expansion of previous service projects successfully carried out by Gene Bridges for BASF.
'We feel confident that our know-how combined with BASF's excellent technical possibilities will result in a significant acceleration of strain development,' said Dr Tim Zeppenfeld, who is jointly responsible for this project at Gene Bridges.